Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Bausch & Lomb Zyoptix System Gets FDA Nod

Facebook Twitter LinkedIn Email Comments
ROCHESTER, N.Y., June 4 -- The US Food and Drug Administration (FDA) has accepted Bausch & Lomb's modular premarket approval application (PMA) for its Zyoptix system for customized vision correction, the company announced.

Bausch & Lomb chairman and CEO Ronald L. Zarrella said, "With our Zyoptix system, Bausch & Lomb was the first company to offer refractive surgeons and their patients truly personalized laser vision correction technology in Europe, Asia, Latin America and Canada. Our PMA submission to the FDA is a key step toward bringing this advanced technology into the important US market."

The Zyoptix system combines the Technolas 217z excimer laser with the Zyoptix diagnostic workstation, Zylink customized treatment calculation software and the Hansatome microkeratome. The Zylink software was developed solely for use with the Zyoptix system.
Jun 2002
News & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.